Navigation Links
Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth

erty and equipment, net 8,228 7,146

Long-term investments 24,668 -

Other noncurrent assets 1,451 1,441

Total assets $160,334 $149,844

Liabilities and stockholders' equity:

Accounts payable and accrued expenses $22,779 $20,790

Amounts due to related parties 4,513 2,311

Deferred revenue 3,199 3,939

Capital lease obligations 472 485

Total current liabilities 30,963 27,525

Capital lease obligations, net of current

portion 689 794

Deferred revenue, net of current portion 473 421

Other long-term liabilities 240 226

Total stockholders' equity 127,969 120,878

Total liabilities and stockholders' equity $160,334 $149,844

To supplement our consolidated financial statements presented in

accordance with GAAP, Cynosure uses the following measures defined as

non-GAAP financial measures by the SEC: non-GAAP gross profit, non-GAAP

income from operations, non-GAAP net income and non-GAAP diluted earnings

per share. The presentation of this financial information is not intended

to be considered in isolation or as a substitute for the financial

information prepared and presented in accordance with GAAP. In addition,

the non-GAAP financial measures included in this press release may be

different from, and therefore not comparable to, similar measures used by

other companies. Although certain non-GAAP financial measures used in this

release exclude the accounting

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results
Post Your Comments:
(Date:10/8/2015)... ... 08, 2015 , ... Cystic fibrosis (CF) is a genetic ... and results in dysfunction of the lungs and the gastrointestinal (GI) tract. In ... is very difficult to clear, blocks the airways and the glands, and creates ...
(Date:10/7/2015)... Worth, Texas (PRWEB) , ... October 07, 2015 ... ... Cell Institute ( ) will present a public educational seminar on the ... on Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton ...
(Date:10/7/2015)... Oct. 7, 2015  October is National Liver Awareness Month ... to donating a portion of its October profits to ... practices. ... variety of ways; whether it is by providing the ... with researchers in different disease and investigation areas, or ...
(Date:10/7/2015)... ... October 07, 2015 , ... ReliantHeart, ... S. Russel Craig of Spectral Platforms, and Michael Ward of Wrenward Medical Systems ... and consulting experience. Currently he is Executive Vice President of Strategic Relationships and ...
Breaking Biology Technology:
... WEST LAFAYETTE, Ind. - A team of Purdue University ... that has successfully created ultrapure material that captures new ... quantum computing. The material, gallium arsenide, is used ... the laws of single-particle physics, but instead are governed ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today reported ... For the second quarter ended June 30, 2011, Sangamo reported ... share, compared to a net loss of $3.9  million, or ... of June 30, 2011, the company had cash, cash equivalents ...
... NEW YORK, July 27, 2011 Keryx Biopharmaceuticals, Inc. ... patient enrollment in its Phase 3 registration trial of ... cancer.  This Phase 3 trial, with over 430 randomized ... Assessment (SPA) with the Food and Drug Administration (FDA) ...
Cached Biology Technology:
(Date:9/10/2015)... -- Report Details Emerging Biological Drugs ... Revenue Prospects to Help You Stay Ahead ... drug classes? Get the latest technological and commercial ... data and industry knowledge, benefitting your influence. And ... sales predictions. Visiongain,s new study reveals what,s ...
(Date:9/10/2015)... ATLANTA , Sept. 10, 2015 ... Cleveland Clinic Wellness to create an interactive, image-based ... self-service health and wellness kiosk.  The unique assessment ... Age"— a number that suggests an individual,s biological ... biometric values as measured by the kiosk. ...
(Date:9/9/2015)... Columbia , Sept. 9, 2015  NuData ... organizational and solution-based milestones, furthering the company,s commitment ... of online fraud. NuData Security,s online ... enhancing the company,s growth cycle. The product combines ... to determine good user behavior from fraudulent behavior, ...
Breaking Biology News(10 mins):
... June 30, 2011 Jerusalem, Israel The Israeli ... industrial R&D and innovation, has released new data from ... and strategic consulting firm Applied Economics Ltd., to mark ... anniversary. The study presents the proven impact of ...
... many plastic cards currently crowd your wallet, one day ... The Department of Homeland Security(DHS),s Science and Technology Directorate ... a portable device used for measuring exposure to ionizing ... unlikely event of a nuclear accident or dirty bomb. ...
... Calif. Susan R. Wessler , who holds ... distinguished professor of genetics in the Department of ... California, Riverside, has been named the recipient of the ... ) 2012 Excellence in Science Award. The award ...
Cached Biology News:
Collected from sexually mature mice....
Collected from 8-12 week-old New Zealand or Californian rabbits.,Supplied in lyophilized form....
Biology Products: